Back to search

Ireland· IE-PA-EU/1/05/320/005

Noxafil 300 mg gastro-resistant powder for oral suspension

A posaconazole product containing posaconazole, registered in Ireland by Merck Sharp & Dohme BV,. The same ATC class is registered in 18 of our 19 countries.

ATC J02AC04

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedNoxafil 300 mg gastro-resistant powde…ATCJ02AC04REGISTER NO.IE-PA-EU/1/05/320/005PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Posaconazole is registered in 18 of 19 countries.

Countries holding a registration under ATC J02AC04 (posaconazole), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 10 of them publish a price we can compare per daily dose

Posaconazole · ATC J02AC04

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of posaconazole costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), the median price runs from $6.09 in United States to $82.67 in Italy — a ×14 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Posaconazole · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

  • IT Italy$82.67
  • CH Switzerland$74.94
  • US United States$6.09 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Posaconazole
Manufacturer
Merck Sharp & Dohme BV,
Country
Ireland (IE)
ATC code
J02AC04
ATC class
Posaconazole
Defined daily dose
0.3 g, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/05/320/005

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

415 interactions on record for posaconazole.

Graded by severity as the source publishes them — 143 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Posaconazole · interactions on record

415 records

  • 143 severe
  • 219 moderate
  • 7 minor
  • 27 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • NaloxegolA06AH03severe

19 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Posaconazole in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All posaconazole products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Posaconazol Altan, Posaconazol Ratiopharm
  • Belgium · Posaconazol Ab, Posaconazol Sandoz
  • Czechia · Gudivin, Posaconazole Accord
  • Germany · Ossmiq, Posaconazol
  • Denmark · Posaconazol Stada, Posaconazol Teva B.V.
  • Estonia · Ossmiq, Posaconazol
  • Spain · Posaconazol, Posaconazol Abdi
  • Finland · Posaconazol Vivanta, Posaconazole
  • France · Posaconazole Accord, Posaconazole Altan
  • United Kingdom (Northern Ireland) · Posaconazol Msn Laboratories, Posaconazole
  • Greece · Posaconazole Genepharm, Posaconazole Stada
  • Croatia · Posakonazol Abdi, Posakonazol Msn
  • Hungary · Gudivin, Posaconazol Accord
  • Iceland · Noxafil, Posaconazole Accord
  • Italy · Posaconazole Eg Stada, Posaconazole Mylan
  • Liechtenstein · Noxafil, Posaconazole Accord
  • Lithuania · Posaconazole Stada
  • Latvia · Posaconazole Stada
  • Malta · Posaconazole, Posaconazole Anfarm
  • Netherlands · Posaconazol 100 Mg, Posaconazol Abdi
  • Norway · Noxafil, Posaconazole Accord
  • Poland · Posaconazole Accord, Posaconazole Aurovitas
  • Portugal · Posaconazol Almovar, Posaconazol Anfarm
  • Romania · Posaconazol, Posaconazol Accord
  • Sweden · Posaconazole, Posaconazole Amarox
  • Slovenia · Posaconazol Msn, Posakonazol Stada
  • Slovakia · Posaconazol Msn, Posaconazole Msn

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cdeba3d7-d194-4306-a702-1b3998986e40
GET /v1/drugs/cdeba3d7-d194-4306-a702-1b3998986e40?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Gastro-resistant powder for oral suspension",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "J02AC04"
  ],
  "strength": null,
  "pa_number": "EU/1/05/320/005",
  "substances": [
    "Posaconazole"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "04/02/2022",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about posaconazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.